The North America aesthetic dermatology market is projected to register a substantial CAGR of 10.3% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2020, and the forecast period is 2022 to 2029.
Market Segmentation:
North America Dermatology Market, By Product Type (Medicines and Devices), Surgery Type (Minimally Invasive and Non-Invasive), Treatment Type (Face Treatment and Body Treatment), Application (Skin Rejuvenation, Skin Resurfacing, Skin Tightening, Hair Removal, Pigmented & Vascular Lesions, Tattoo Removal, Scar, Acne, Dyschromia, Skin Tags, Psoriasis, Warts, Hyperhidrosis, Moles and Freckles and Others), Gender (Female and Male), End User (Hospitals, Dermatology Clinics, Surgical Centers, Spa Clinics and Others), Distribution Channel (Direct Tender and Retail Sales), Country (U.S., Canada, Mexico) - Industry Trends and Forecast to 2029.
Some of the major factors contributing to the growth of North America aesthetic dermatology market are:
- Increasing spending on aesthetic procedures
- Growing technological advancements
Market Players:
The major companies which are dealing in the North America aesthetic dermatology market are listed below:
- AbbVie Inc.
- Henry Schein, Inc.
- Merz Pharma, Cutera
- Cynosure. Inc. (A Subsidiary of Hologic, Inc.)
- Candela Medical, Bausch Health Companies Inc.
- Evolus, Inc.
- Medytox
- LUTRONIC
- HUGEL, Inc.
- El. En. S.p.A.
- Hoahai
- REVANCE THERAPEUTICS
- Lumenis Be Ltd.
- Venus Concept
- Alma Lasers
- Fotona
- Aesthetic Biomedical
- ThermiGen, LLC.
- R2 TECHNOLOGIES, INC. (A Subsidiary of INNOVATE Corp.)
- Sensus Healthcare, Inc.
- Aesthetic Technology Limited
- DELEO
- Aerolase Corp.
- Sciton
- Image Derm, Inc.
- PhotoMedex
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 OBJECTIVES OF THE STUDY
- 1.2 MARKET DEFINITION
- 1.3 OVERVIEW OF THE NORTH AMERICA AESTHETIC DERMATOLOGY MARKET
- 1.4 LIMITATIONS
- 1.5 MARKETS COVERED
2 MARKET SEGMENTATION
- 2.1 MARKETS COVERED
- 2.2 GEOGRAPHICAL SCOPE
- 2.3 YEARS CONSIDERED FOR THE STUDY
- 2.4 CURRENCY AND PRICING
- 2.5 DBMR TRIPOD DATA VALIDATION MODEL
- 2.6 MULTIVARIATE MODELLING
- 2.7 PRODUCT TYPE LIFELINE CURVE
- 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
- 2.9 DBMR MARKET POSITION GRID
- 2.10 MARKET END USER COVERAGE GRID
- 2.11 VENDOR SHARE ANALYSIS
- 2.12 SECONDARY SOURCES
- 2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 PORTERS FIVE FORCES
- 4.2 PESTEL ANALYSIS
5 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: REGULATIONS
- 5.1 U.S.
- 5.2 EUROPEAN UNION
- 5.3 CHINA
- 5.4 THAILAND
- 5.5 BRAZIL
6 MARKET OVERVIEW
- 6.1 DRIVERS
- 6.1.1 GROWING DESIRE TO IMPROVE ONE'S APPEARANCE
- 6.1.2 RISE IN PREFERENCE FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES
- 6.1.3 ADVANCEMENT IN HEALTHCARE TECHNOLOGY & INFRASTRUCTURE
- 6.1.4 INCREASE IN AESTHETIC EXPENDITURE
- 6.2 RESTRAINTS
- 6.2.1 HIGH COST OF AESTHETIC SURGICAL PROCEDURES
- 6.2.2 SIDE EFFECTS RELATED TO AESTHETIC TREATMENTS
- 6.3 OPPORTUNITIES
- 6.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS
- 6.3.2 INCREASE IN RESEARCH AND DEVELOPMENT
- 6.3.3 DECREASED DISPARITY BETWEEN MEN AND WOMEN FOR AESTHETIC PROCEDURES
- 6.3.4 GROW IN AWARENESS OF AESTHETIC PROCEDURES
- 6.4 CHALLENGES
- 6.4.1 LACK OF SKILLED PROFESSIONALS
- 6.4.2 LONG APPROVAL TIME ASSOCIATED WITH PRODUCT LAUNCH
7 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE
- 7.1 OVERVIEW
- 7.2 MEDICINES
- 7.2.1 BOTOX
- 7.2.2 DERMAL FILLERS
- 7.2.3 OTHERS
- 7.3 DEVICES
- 7.3.1 ENERGY BASED DEVICE
- 7.3.1.1 LASER BASED DEVICE
- 7.3.1.1.1 NON-ABLATIVE
- 7.3.1.1.1.1 PULSE ENERGY LASER
- 7.3.1.1.1.2 ND:YAG
- 7.3.1.1.1.3 DIODE LASER
- 7.3.1.1.1.4 OTHERS
- 7.3.1.1.2 ABLATIVE
- 7.3.1.1.2.1 CARBON DIOXIDE LASER
- 7.3.1.1.2.2 ER:YAG LASER
- 7.3.1.1.2.3 COMBINED CO2 ER:YAG LASER
- 7.3.1.2 RADIOFREQUENCY (RF) BASED DEVICE
- 7.3.1.3 LIGHT BASED DEVICE
- 7.3.1.4 ULTRASOUND BASED DEVICE
- 7.3.1.5 OTHERS
- 7.3.2 NON-ENERGY BASED DEVICE
- 7.3.2.1 MICRODERMABRASION DEVICES
- 7.3.2.2 THREADS
- 7.3.2.3 CRYOTHERAPY DEVICES
- 7.3.2.4 OTHERS
8 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY SURGERY TYPE
- 8.1 OVERVIEW
- 8.2 MINIMALLY INVASIVE
- 8.3 NON-INVASIVE
9 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY TREATMENT TYPE
- 9.1 OVERVIEW
- 9.2 FACE TREATMENT
- 9.2.1 SKIN REJUVENATION
- 9.2.2 SKIN RESURFACING
- 9.2.3 SKIN TIGHTENING
- 9.2.4 HAIR REMOVAL
- 9.2.5 ACNE
- 9.2.6 PIGMENTED & VASCULAR LESIONS
- 9.2.7 TATTOO REMOVAL
- 9.2.8 SCAR
- 9.2.9 DYSCHROMIA
- 9.2.10 PSORIASIS
- 9.2.11 SKIN TAGS
- 9.2.12 WARTS
- 9.2.13 MOLES & FRECKLES
- 9.2.14 HYPERHIDROSIS
- 9.2.15 OTHERS
- 9.3 BODY TREATMENT
- 9.3.1 SKIN REJUVENATION
- 9.3.2 SKIN RESURFACING
- 9.3.3 SKIN TIGHTENING
- 9.3.4 HAIR REMOVAL
- 9.3.5 PIGMENTED & VASCULAR LESIONS
- 9.3.6 TATTOO REMOVAL
- 9.3.7 SCAR
- 9.3.8 SKIN TAGS
- 9.3.9 HYPERHIDROSIS
- 9.3.10 PSORIASIS
- 9.3.11 DYSCHROMIA
- 9.3.12 WARTS
- 9.3.13 MOLES & FRECKLES
- 9.3.14 ACNE
- 9.3.15 OTHERS
10 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY APPLICATION
- 10.1 OVERVIEW
- 10.2 SKIN REJUVENATION
- 10.3 SKIN RESURFACING
- 10.4 SKIN TIGHTENING
- 10.5 HAIR REMOVAL
- 10.6 PIGMENTED & VASCULAR LESIONS
- 10.7 TATTOO REMOVAL
- 10.8 SCAR
- 10.9 ACNE
- 10.10 DYSCHROMIA
- 10.11 SKIN TAGS
- 10.12 PSORIASIS
- 10.13 WARTS
- 10.14 HYPERHIDROSIS
- 10.15 MOLES & FRECKLES
- 10.16 OTHERS
11 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY GENDER
- 11.1 OVERVIEW
- 11.2 FEMALE
- 11.3 MALE
12 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY END USER
- 12.1 OVERVIEW
- 12.2 HOSPITALS
- 12.3 DERMATOLOGY CLINICS
- 12.4 SURGICAL CENTERS
- 12.5 SPA CLINICS
- 12.6 OTHERS
13 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY DISTRIBUTION CHANNEL
- 13.1 OVERVIEW
- 13.2 DIRECT TENDER
- 13.3 RETAIL SALES
14 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY REGION
- 14.1 NORTH AMERICA
- 14.1.1 U.S.
- 14.1.2 CANADA
- 14.1.3 MEXICO
15 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: COMPANY LANDSCAPE
- 15.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
16 SWOT ANALYSIS
17 COMPANY PROFILE
- 17.1 ABBVIE INC.
- 17.1.1 COMPANY SNAPSHOT
- 17.1.2 RECENT FINANCIALS
- 17.1.3 COMPANY SHARE ANALYSIS
- 17.1.4 PRODUCT PORTFOLIO
- 17.1.5 RECENT DEVELOPMENTS
- 17.2 BAUSCH HEALTH COMPANIES INC.
- 17.2.1 COMPANY SNAPSHOT
- 17.2.2 RECENT FINANCIALS
- 17.2.3 COMPANY SHARE ANALYSIS
- 17.2.4 PRODUCT PORTFOLIO
- 17.2.5 RECENT DEVELOPMENT
- 17.3 HENRY SCHEIN, INC.
- 17.3.1 COMPANY SNAPSHOT
- 17.3.2 RECENT FINANCIALS
- 17.3.3 COMPANY SHARE ANALYSIS
- 17.3.4 PRODUCT PORTFOLIO
- 17.3.5 RECENT DEVELOPMENTS
- 17.4 MERZ PHARMA
- 17.4.1 COMPANY SNAPSHOT
- 17.4.2 COMPANY SHARE ANALYSIS
- 17.4.3 PRODUCT PORTFOLIO
- 17.4.4 RECENT DEVELOPMENTS
- 17.5 CANDELA MEDICAL
- 17.5.1 COMPANY SNAPSHOT
- 17.5.2 COMPANY SHARE ANALYSIS
- 17.5.3 PRODUCT PORTFOLIO
- 17.5.4 RECENT DEVELOPMENT
- 17.6 AEROLASE CORP.
- 17.6.1 COMPANY SNAPSHOT
- 17.6.2 PRODUCT PORTFOLIO
- 17.6.3 RECENT DEVELOPMENTS
- 17.7 AESTHETIC TECHNOLOGY LIMITED
- 17.7.1 COMPANY SNAPSHOT
- 17.7.2 PRODUCT PORTFOLIO
- 17.7.3 RECENT DEVELOPMENTS
- 17.8 AESTHETIC BIOMEDICAL
- 17.8.1 COMPANY SNAPSHOT
- 17.8.2 PRODUCT PORTFOLIO
- 17.8.3 RECENT DEVELOPMENTS
- 17.9 ALMA LASERS
- 17.9.1 COMPANY SNAPSHOT
- 17.9.2 PRODUCT PORTFOLIO
- 17.9.3 RECENT DEVELOPMENTS
- 17.10 BIOTECH ITALIA SRL
- 17.10.1 COMPANY SNAPSHOT
- 17.10.2 PRODUCT PORTFOLIO
- 17.10.3 RECENT DEVELOPMENTS
- 17.11 CUTERA
- 17.11.1 COMPANY SNAPSHOT
- 17.11.2 RECENT FINANCIALS
- 17.11.3 PRODUCT PORTFOLIO
- 17.11.4 RECENT DEVELOPMENTS
- 17.12 CYNOSURE. INC. (A SUBSIDIARY OF HOLOGIC, INC.)
- 17.12.1 COMPANY SNAPSHOT
- 17.12.2 PRODUCT PORTFOLIO
- 17.12.3 RECENT DEVELOPMENT
- 17.13 DELEO
- 17.13.1 COMPANY SNAPSHOT
- 17.13.2 PRODUCT PORTFOLIO
- 17.13.3 RECENT DEVELOPMENTS
- 17.14 EL. EN. S.P.A.
- 17.14.1 COMPANY SNAPSHOT
- 17.14.2 RECENT FINANCIALS
- 17.14.3 PRODUCT PORTFOLIO
- 17.14.4 RECENT DEVELOPMENTS
- 17.15 EVOLUS, INC.
- 17.15.1 COMPANY SNAPSHOT
- 17.15.2 RECENT FINANCIALS
- 17.15.3 PRODUCT PORTFOLIO
- 17.15.4 RECENT DEVELOPMENT
- 17.16 FOTONA
- 17.16.1 COMPANY SNAPSHOT
- 17.16.2 PRODUCT PORTFOLIO
- 17.16.3 RECENT DEVELOPMENT
- 17.17 HAOHAI BIOLOGICAL TECHNOLOGY
- 17.17.1 COMPANY SNAPSHOT
- 17.17.2 RECENT FINANCIALS
- 17.17.3 PRODUCT PORTFOLIO
- 17.17.4 RECENT DEVELOPMENTS
- 17.18 HUGEL, INC.
- 17.18.1 COMPANY SNAPSHOT
- 17.18.2 RECENT FINANCIALS
- 17.18.3 PRODUCT PORTFOLIO
- 17.18.4 RECENT DEVELOPMENT
- 17.19 IMAGE DERM, INC.
- 17.19.1 COMPANY SNAPSHOT
- 17.19.2 PRODUCT PORTFOLIO
- 17.19.3 RECENT DEVELOPMENTS
- 17.20 LUMENIS BE LTD.
- 17.20.1 COMPANY SNAPSHOT
- 17.20.2 PRODUCT PORTFOLIO
- 17.20.3 RECENT DEVELOPMENT
- 17.21 LUTRONIC
- 17.21.1 COMPANY SNAPSHOT
- 17.21.2 RECENT FINANCIALS
- 17.21.3 PRODUCT PORTFOLIO
- 17.21.4 RECENT DEVELOPMENT
- 17.22 MEDENCY
- 17.22.1 COMPANY SNAPSHOT
- 17.22.2 PRODUCT PORTFOLIO
- 17.22.3 RECENT DEVELOPMENTS
- 17.23 MEDYTOX
- 17.23.1 COMPANY SNAPSHOT
- 17.23.2 RECENT FINANCIALS
- 17.23.3 PRODUCT PORTFOLIO
- 17.23.4 RECENT DEVELOPMENT
- 17.24 PHOTOMEDEX
- 17.24.1 COMPANY SNAPSHOT
- 17.24.2 PRODUCT PORTFOLIO
- 17.24.3 RECENT DEVELOPMENTS
- 17.25 R2 TECHNOLOGIES, INC. (A SUBSIDIARY OF INNOVATE CORP.)
- 17.25.1 COMPANY SNAPSHOT
- 17.25.2 PRODUCT PORTFOLIO
- 17.25.3 RECENT DEVELOPMENTS
- 17.26 REVANCE THERAPEUTICS
- 17.26.1 COMPANY SNAPSHOT
- 17.26.2 RECENT FINANCIALS
- 17.26.3 PRODUCT PORTFOLIO
- 17.26.4 RECENT DEVELOPMENTS
- 17.27 SCITON
- 17.27.1 COMPANY SNAPSHOT
- 17.27.2 PRODUCT PORTFOLIO
- 17.27.3 RECENT DEVELOPMENTS
- 17.28 SENSUS HEALTHCARE, INC.
- 17.28.1 COMPANY SNAPSHOT
- 17.28.2 PRODUCT PORTFOLIO
- 17.28.3 RECENT DEVELOPMENT
- 17.29 THERMIGEN, LLC.
- 17.29.1 COMPANY SNAPSHOT
- 17.29.2 PRODUCT PORTFOLIO
- 17.29.3 RECENT DEVELOPMENTS
- 17.30 VENUS CONCEPT
- 17.30.1 COMPANY SNAPSHOT
- 17.30.2 RECENT FINANCIALS
- 17.30.3 PRODUCT PORTFOLIO
- 17.30.4 RECENT DEVELOPMENTS
18 QUESTIONNAIRE
19 RELATED REPORTS